These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Comparative reaction engineering studies for succinic acid production from sucrose by metabolically engineered Escherichia coli in fed-batch-operated stirred tank bioreactors.
    Author: Hoefel T, Faust G, Reinecke L, Rudinger N, Weuster-Botz D.
    Journal: Biotechnol J; 2012 Oct; 7(10):1277-87. PubMed ID: 22588847.
    Abstract:
    This study presents a comparative reaction engineering analysis of metabolically engineered sucrose-utilizing Escherichia coli derived from E. coli K12 MG1655 for the anaerobic production of succinic acid. Production capacities of 16 different recombinant strains were evaluated in 48 parallel fed-batch-operated milliliter-scale stirred tank bioreactors (10 mL) with continuous CO₂ sparging. The effects of recombinant sucrose-utilization systems (csc-operon or scr-operon), enhancements of anaplerotic reactions (pck, ppc, maeA, maeB or heterologous pyc) and gene deletions (ldhA, adhE, ack-pta and ptsG) were studied with respect to the overall process performances of the respective recombinant strains. Both sucrose-utilization systems enabled the production of succinic acid from sucrose in E. coli K12 MG1655. Maximum succinate production was observed by overexpressing the pyruvate carboxylase from Corynebacterium glutamicum resulting in a succinate concentration of 26.8 g L⁻¹ after 48 h and a cell-specific productivity of 0.14 g g⁻¹ h⁻¹. Further experiments in a fed-batch-operated laboratory-scale stirred tank bioreactor (2 L) showed that micro-aerobic conditions preceding the anaerobic phase enhance succinic acid production of E. coli K12 MG1655-derived strains. The work demonstrates the importance of parallel approaches within the scope of applied metabolic engineering studies.
    [Abstract] [Full Text] [Related] [New Search]